Heidelberg Pharma AG
FSX:HPHA.DE
2.52 (EUR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 9.859 | 18.514 | 1.75 | 8.488 | 7.309 | 3.668 | 1.9 | 1.362 | 2.284 | 3.597 | 13.317 | 17.841 | 9.877 | 0 | 10 | 0 | 0 | 0 |
| Cost of Revenue
| 4.131 | 4.679 | 4.712 | 5.6 | 3.739 | 2.208 | 0.957 | 0.809 | 1.14 | 1.355 | 3.678 | 6.746 | 4.165 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 5.728 | 13.835 | -2.962 | 2.888 | 3.57 | 1.46 | 0.943 | 0.553 | 1.144 | 2.242 | 9.639 | 11.095 | 5.712 | 0 | 10 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.581 | 0.747 | -1.693 | 0.34 | 0.488 | 0.398 | 0.496 | 0.406 | 0.501 | 0.623 | 0.724 | 0.622 | 0.578 | 0 | 1 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 28.075 | 26.377 | 18.75 | 18.287 | 10.942 | 10.679 | 9.323 | 6.119 | 4.445 | 5.572 | 12.427 | 12.78 | 15.641 | 19.704 | 21.823 | 20.157 | -16.23 | -10.666 |
| General & Administrative Expenses
| 5.248 | 4.816 | 3.986 | 3.581 | 3.145 | 2.966 | 2.748 | 1.954 | 4.512 | 3.177 | 4.244 | 4.856 | 5.29 | 4.722 | 4.055 | 4.445 | 0 | 0 |
| Selling & Marketing Expenses
| 0.973 | 1.17 | 0.496 | 0.393 | 0.282 | 0.192 | 0.207 | 0.222 | 0.341 | 0.483 | 3.72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.805 | 4.816 | 3.986 | 3.581 | 3.145 | 2.966 | 2.748 | 1.954 | 4.512 | 3.177 | 4.244 | 4.856 | 5.29 | 4.722 | 4.055 | 4.445 | 0 | 0 |
| Other Expenses
| 0.634 | 0.977 | 0.094 | -0.416 | -0.152 | 0.323 | 0.087 | 0.061 | 1.231 | 1.11 | 0.92 | 2.369 | -1.836 | -1.314 | -3.013 | -3.208 | 0 | 0 |
| Operating Expenses
| 33.246 | 32.169 | 22.831 | 21.452 | 13.934 | 13.516 | 11.788 | 6.983 | 8.97 | 8.958 | 19.65 | 20.005 | 19.095 | 23.112 | 22.864 | 21.394 | -16.23 | -10.666 |
| Operating Income
| -27.518 | -18.335 | -25.631 | -18.564 | -10.364 | -11.672 | -10.753 | -6.361 | -6.517 | -5.576 | -4.964 | -8.91 | -13.383 | -23.112 | -12.864 | -21.394 | -23.927 | -18.249 |
| Operating Income Ratio
| -2.791 | -0.99 | -14.648 | -2.187 | -1.418 | -3.182 | -5.659 | -4.67 | -2.853 | -1.55 | -0.373 | -0.499 | -1.355 | 0 | -1.286 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 7.172 | 0.549 | -0.508 | 0.195 | 0.221 | 0.57 | 0.199 | 0.438 | 1.312 | 1.108 | 4.971 | -0.478 | -0.541 | 0.02 | 0.15 | 0.961 | 0 | 0 |
| Income Before Tax
| -20.346 | -17.786 | -26.139 | -18.369 | -10.143 | -11.672 | -10.97 | -6.38 | -6.514 | -5.608 | -5.04 | -9.388 | -13.924 | -23.092 | -12.714 | -20.433 | 0 | 0 |
| Income Before Tax Ratio
| -2.064 | -0.961 | -14.938 | -2.164 | -1.388 | -3.182 | -5.774 | -4.684 | -2.852 | -1.559 | -0.378 | -0.526 | -1.41 | 0 | -1.271 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 1.916 | 0.494 | 0.005 | 0.005 | 0.57 | 0.417 | 0.009 | 0.038 | 0.093 | 0 | 0.003 | 0.002 | 0.006 | 0.015 | 0.015 | 0 | 0 |
| Net Income
| -20.346 | -19.702 | -26.633 | -18.374 | -10.148 | -11.672 | -10.97 | -6.389 | -6.552 | -5.701 | -5.04 | -9.391 | -13.926 | -23.089 | -12.729 | -20.448 | 0 | 0 |
| Net Income Ratio
| -2.064 | -1.064 | -15.22 | -2.165 | -1.388 | -3.182 | -5.774 | -4.691 | -2.868 | -1.585 | -0.378 | -0.526 | -1.41 | 0 | -1.273 | 0 | 0 | 0 |
| EPS
| -0.44 | -0.53 | -0.82 | -0.61 | -0.36 | -0.41 | -0.76 | -0.53 | -0.75 | -0.66 | -0.61 | -1.37 | -2.54 | -5.13 | -3.55 | -6.36 | 0 | 0 |
| EPS Diluted
| -0.44 | -0.53 | -0.82 | -0.61 | -0.36 | -0.41 | -0.76 | -0.51 | -0.72 | -0.66 | -0.61 | -1.37 | -2.54 | -5.13 | -3.55 | -6.36 | 0 | 0 |
| EBITDA
| -26.64 | -16.205 | -24.841 | -17.631 | -9.817 | -11.303 | -10.346 | -6.08 | -6.254 | -5 | -7.048 | -8.238 | -12.852 | -22.87 | -12.469 | -20.169 | 16.488 | 10.857 |
| EBITDA Ratio
| -2.702 | -0.875 | -14.196 | -2.077 | -1.343 | -3.082 | -5.445 | -4.464 | -2.738 | -1.39 | -0.529 | -0.462 | -1.301 | 0 | -1.247 | 0 | 0 | 0 |